Chemotherapy-induced peripheral neuropathy and its determinants among adult cancer patients on chemotherapy in northwest Ethiopia oncology centers, 2022

Chemotherapy-induced peripheral neuropathy is a common adverse event among Ethiopian cancer patients treated with various chemotherapeutic drugs. Therefore, it is necessary to establish more effective diagnostic methods and incorporate validated assessment tools, such as the European Organization for Research and Treatment of Cancer tools, either alone or in combination with other clinical instruments, into the routine evaluation of all patients receiving chemotherapeutic drug.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2024-12-10
DOI
https://doi.org/10.3389/fonc.2024.1420518
Citations
2
Primary Topic
Cancer Treatment and Pharmacology
Type
article
Field-Weighted Citation Impact
0.57
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemotherapy-induced peripheral neuropathy and its determinants among adult cancer patients on chemotherapy in northwest Ethiopia oncology centers, 2022

Melsew Dagne Abate, Addis Wondmagegn Alamaw, Tesfaye Engdaw Habtie, Zenaw T Wolie et al.
2 citations
Frontiers in Oncology
Cancer Treatment and Pharmacology
0.57
article

Chemotherapy-induced peripheral neuropathy and its determinants among adult cancer patients on chemotherapy in northwest Ethiopia oncology centers, 2022

Melsew Dagne Abate, Addis Wondmagegn Alamaw, Tesfaye Engdaw Habtie, Zenaw T Wolie, Gebremeskel Kibret Abebe, Haymanot Zeleke Mitiku
article en
2 citations

Abstract

Chemotherapy-induced peripheral neuropathy is a common adverse event among Ethiopian cancer patients treated with various chemotherapeutic drugs. Therefore, it is necessary to establish more effective diagnostic methods and incorporate validated assessment tools, such as the European Organization for Research and Treatment of Cancer tools, either alone or in combination with other clinical instruments, into the routine evaluation of all patients receiving chemotherapeutic drug.

Frontiers in OncologyVol. 14
Jigjiga University (ET), Woldia University (ET), Injibara University (ET), Debre Markos University (ET)
Good health and well-being
Openalex Percentile: Top 26%
Cancer Treatment and Pharmacology
0.57
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.